Debut Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Delhi, Delhi, India, established in 1996.
1996 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Debut Pharmaceuticals Private Limited

Debut Pharmaceuticals Private Limited, a struck off private limited company, was established on 07 October 1996 in Delhi, Delhi, India. Engaging in retailers within the trading sector, it holds CIN: U51397DL1996PTC082455. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.14 M.

Its leadership includes Sanjay Kakar (Additional Director), Deepa Kakar (Director). Past directors included Sumit Jain, Saroj Gupta, Ramji Gupta. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at 208, Iind Floor, W.P.-476, Shiv Market, Wazirpur Village, Ashok Vihar,, Delhi, Delhi, 110052.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL1996PTC082455

  • Registration Number

    082455

  • Incorporation Date

    07 October 1996

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.14 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.14 M
  • Company Age 29 Year, 8 Months
  • Last Filing with ROC 31 Mar 2016
Company report

Debut Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Debut Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Debut Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Kakar Additional Director 31 Dec 2012 Current
Deepa Kakar Director 16 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 16 Sep 2013 Past
Pramod Abcsdd Director 31 Dec 2012 Past
Pramod Abcsdd Director 09 Jan 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Debut Pharmaceuticals.

Enhance accessibility to Debut Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Debut Pharmaceuticals revenue growth over time
Debut Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Debut Pharmaceuticals?

In 2016, Debut Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Debut Pharmaceuticals?

Unlock and access historical data on people associated with Debut Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Debut Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Debut Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Debut Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Debut Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Debut Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was completed.

  • Director Appointment

    Deepa Kakar was appointed as a Director was appointed as a Director on 16 Sep 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sanjay Kakar was appointed as a Additional Director was appointed as a Additional Director on 31 Dec 2012 & has been associated with this company since 13 years 6 months . was documented.

  • Company Incorporation

    The activity Debut Pharmaceuticals Private Limited was registered on 07 Oct 1996 with Roc Delhi & aged 29 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Debut Pharmaceuticals Private Limited?

The CIN of Debut Pharmaceuticals Private Limited is U51397DL1996PTC082455.

Where is Debut Pharmaceuticals Private Limited headquartered?

Debut Pharmaceuticals Private Limited is headquartered at 208, Iind Floor, W.P.-476, Shiv Market, Wazirpur Village, Ashok Vihar,, Delhi, Delhi, 110052.

When was Debut Pharmaceuticals Private Limited incorporated?

Debut Pharmaceuticals Private Limited was incorporated on 07 October 1996.

Who are the current directors of Debut Pharmaceuticals Private Limited?

The current directors of Debut Pharmaceuticals Private Limited are

What is the primary industry of Debut Pharmaceuticals Private Limited?

The primary industry of Debut Pharmaceuticals Private Limited is Trading.

Is Debut Pharmaceuticals Private Limited a listed company?

Debut Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Debut Pharmaceuticals Private Limited?

The authorized capital of Debut Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.14 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available